InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Johnson Waynick Denelle, Dirigeant. Director active across 1 companies, notably UCB. Aggregated, 2 reports have been published. The latest transaction was disclosed on 2 April 2026 — Purchase. Regulator: FSMA. All data is free.
Declarations2 total
02,464 shares0
Options /warrants for employees or managersOff exchange
FSMA:ucb-190·
Ideal exit: 28 Dec 2026 (T+270)
03,873 shares0
ShareOff exchange
FSMA:ucb-108·
Ideal exit: 27 Dec 2026 (T+270)
2 of 2 declarations
About Johnson Waynick Denelle
Denelle Johnson Waynick is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.
